ResMed Inc.RMDNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+4.2%
5Y CAGR+2.1%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+4.2%/yr
vs +3.1%/yr prior
5Y CAGR
+2.1%/yr
Consistent
Acceleration
+1.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 37.18% | +13.6% |
| 2024 | 32.73% | +1.7% |
| 2023 | 32.18% | -2.2% |
| 2022 | 32.88% | -4.8% |
| 2021 | 34.53% | +3.1% |
| 2020 | 33.49% | +23.7% |
| 2019 | 27.08% | -6.8% |
| 2018 | 29.07% | +5.6% |
| 2017 | 27.53% | -3.2% |
| 2016 | 28.43% | - |